Ronald Adamolekun

The financials of the company out on Wednesday showed energy sent out dropped to N150.6 billion from N183.5 billion, setting revenue up for a 13.4 per cent decline.

Ethical or prescription drugs alone delivered more than three-fifths of turnover to Fidson last year, making 2025 a banner year for the company.

This is not a buy, sell or hold recommendation but a stock investment guide. You may need to involve your financial advisor before taking investment decisions.

Cost-to-income ratio dropped to 41.4 per cent from 57 per cent one year prior, strengthening earnings.

Turnover leapt to ₦2.5 trillion from ₦2.1 trillion, aided by a rise of 10 per cent in production volume.

Turnover leapt to ₦2.5 trillion from ₦2.1 trillion, aided by a rise of 10 per cent in production volume.

Shares in the corporation had gained 0.6 per cent as of 12:46 WAT in Lagos, where they have primary listing after the results were issued on Thursday.

First HoldCo said the move highlights its directors' confidence in its earnings capacity, enhanced capital position, improving asset quality, diversified revenue streams, and robust outlook for sustained profitability and growth.

The sharp pace of turnover growth could not be matched by after-tax profit, which climbed to ₦191 billion from ₦146.4 billion, as rising costs ate away at revenue.

Population growth, the pressure of urbanisation and increasing healthcare awareness are stoking demand for medicines in Nigeria.